Senior Mental Health Account Lead - Neuroscience

Bristol-Myers Squibb Co; Field (KY); On-site; USD 148,000 - 179,000; Full time

Job summary

Bristol-Myers Squibb Co. seeks a Senior Institutional Mental Health Account Specialist to promote neuroscience products in a defined US territory, building scientific credibility with hospital-based teams and payers.

The role emphasizes compliant promotion, strategic planning, and cross-functional collaboration to improve patient access. You'll engage physicians, pharmacists, and hospital decision-makers, translating data into clinically meaningful discussions, while advancing formulary access

Qualifications

• Advanced scientific degree and/or 5+ years of pharma/biotech experience in healthcare sales/MSL/HCP roles.
• Ability to communicate scientific/clinical data clearly to physicians and clinicians.
• Proven credibility with hospital-based customers and cross-functional teams.
• Experience engaging with P&T committees and understanding formulary/reimbursement processes.

Responsibilities

• Promotes approved indications of BMS products within a defined territory to meet or exceed sales targets.
• Develops territory and account plans and uses insights to inform call plans.
• Engages with HCPs, hospital staff, and P&T committees to improve formulary access and product availability.
• Collaborates cross-functionally to ensure compliant, high-quality customer experiences.

Skills

Territory management

HCP engagement

Cross-functional collaboration

Scientific communication

Negotiation/sales

Account planning

Education

Advanced scientific degree

Tools

CRM systems

Medical on Call technology

Job description

Bristol-Myers Squibb Co. seeks a Senior Institutional Mental Health Account Specialist to promote neuroscience products in a defined US territory, building scientific credibility with hospital-based teams and payers.

The role emphasizes compliant promotion, strategic planning, and cross-functional collaboration to improve patient access. You'll engage physicians, pharmacists, and hospital decision-makers, translating data into clinically meaningful discussions, while advancing formulary access